Lungs
- Study shows new drug targets may boost protein inhibitor, survival for lung cancer patients
- MEK inhibition in KRAS-mutant non-small-cell lung cancer (NSCLC) did not improve survival
- Greater patient selection may be needed for first line nivolumab to improve progression-free survival in advanced lung cancer
- Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression
- First-line pembrolizumab plus chemotherapy significantly improves outcomes in advanced non-small-cell lung cancer
- Significant survival gains with atezolizumab vs docetaxel for non-small-cell lung cancer
- Ceritinib provides longer progression-free survival than chemotherapy in phase III trial of ALK rearranged lung cancer treatment
- Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer
- Blocking Ran protein reverses resistance of lung and breast cancers
- Blood pressure drug may boost effectiveness of lung cancer treatment
- Newly discovered immune cell type protects against lung infections during chemotherapy
- Cancer growth model simulates cell-killing ability of combos
- Whole brain radiotherapy offers little benefit to people whose lung cancer has spread to the brain, despite its widespread use
- Targeting low-oxygen patches inside lung cancer tumors could help prevent drug resistance
- Smokers with newly discovered genetic markers have higher lung cancer risk
- Study: Smokers who switch to e-cigarettes exposed to same levels of nicotine, lower carcinogen levels
- Researchers from CSI Singapore discover new way to inhibit development of lung cancer
- Imaging tests could provide helpful information for genetically linked lung cancer
- Introduction of screening could significantly reduce lung cancer deaths
- Scientists discover new therapeutic target for lung cancer driven by KRAS
- Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
- Statins: could they decrease death risk in four most common cancers?
- CT follow-up sufficient for some lung nodules
- Middle aged more likely to be diagnosed with advanced lung cancer
- Many family physicians have inaccurate knowledge about lung cancer screening
Editorial Board
0